These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20826066)
1. Treg-based therapy and mixed chimerism in small intestinal transplantation: does Treg +BMT equal intestine allograft tolerance? Du JF; Li SY; Yu B; Bai X Med Hypotheses; 2011 Jan; 76(1):77-8. PubMed ID: 20826066 [TBL] [Abstract][Full Text] [Related]
2. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance. He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953 [TBL] [Abstract][Full Text] [Related]
3. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527 [TBL] [Abstract][Full Text] [Related]
4. Rapamycin in combination with donor-specific CD4+CD25+Treg cells amplified in vitro might be realize the immune tolerance in clinical organ transplantation. Zhang C; Shan J; Lu J; Huang Y; Feng L; Long D; Li S; Li Q; Li Y Cell Immunol; 2010; 264(2):111-3. PubMed ID: 20580348 [TBL] [Abstract][Full Text] [Related]
5. Tolerance induction through megadose bone marrow transplantation with two-signal blockade. Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077 [TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Feng G; Wood KJ; Bushell A Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229 [TBL] [Abstract][Full Text] [Related]
8. The role of Foxp3+ regulatory T cells in liver transplant tolerance. Li W; Carper K; Zheng XX; Kuhr CS; Reyes JD; Liang Y; Perkins DL; Thomson AW; Perkins JD Transplant Proc; 2006 Dec; 38(10):3205-6. PubMed ID: 17175223 [TBL] [Abstract][Full Text] [Related]
9. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Hanidziar D; Koulmanda M Curr Opin Organ Transplant; 2010 Aug; 15(4):411-5. PubMed ID: 20613526 [TBL] [Abstract][Full Text] [Related]
10. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells. Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888 [TBL] [Abstract][Full Text] [Related]
12. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras. Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847 [TBL] [Abstract][Full Text] [Related]
13. Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance. Remuzzi G Am J Kidney Dis; 1998 Feb; 31(2):197-212. PubMed ID: 9469488 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]